The Beauty Health Company (NASDAQ:SKIN) Receives Average Recommendation of “Hold” from Brokerages

Shares of The Beauty Health Company (NASDAQ:SKIN) have earned an average recommendation of “Hold” from the eight brokerages that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and one has given a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $2.42.

SKIN has been the subject of several analyst reports. Zacks Research upgraded Beauty Health from a “strong sell” rating to a “hold” rating in a research note on Monday, March 16th. Canaccord Genuity Group reissued a “hold” rating and issued a $1.50 price target on shares of Beauty Health in a research note on Friday, March 13th. TD Cowen lowered their price target on Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a report on Monday, March 16th. Benchmark reiterated a “hold” rating on shares of Beauty Health in a report on Friday, March 13th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $1.60 target price on shares of Beauty Health in a research report on Wednesday, January 14th.

Beauty Health Stock Up 2.7%

Shares of NASDAQ SKIN opened at $1.16 on Tuesday. The firm has a market cap of $148.21 million, a P/E ratio of -5.80 and a beta of 1.20. The company has a debt-to-equity ratio of 3.94, a quick ratio of 1.40 and a current ratio of 1.66. Beauty Health has a 1 year low of $0.78 and a 1 year high of $2.69. The firm’s 50 day moving average price is $1.23 and its 200 day moving average price is $1.47.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. Beauty Health had a negative return on equity of 15.40% and a negative net margin of 3.16%.The company had revenue of $82.37 million during the quarter, compared to the consensus estimate of $78.07 million. As a group, sell-side analysts anticipate that Beauty Health will post -0.25 earnings per share for the current year.

Hedge Funds Weigh In On Beauty Health

A number of hedge funds have recently made changes to their positions in SKIN. Public Employees Retirement System of Ohio purchased a new stake in shares of Beauty Health during the 3rd quarter valued at $26,000. Franklin Resources Inc. purchased a new position in shares of Beauty Health in the 3rd quarter worth $31,000. Zacks Investment Management acquired a new position in Beauty Health in the third quarter valued at $35,000. Ameriprise Financial Inc. acquired a new position in Beauty Health in the third quarter valued at $38,000. Finally, Atom Investors LP purchased a new stake in Beauty Health during the fourth quarter valued at about $29,000. Institutional investors and hedge funds own 93.26% of the company’s stock.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.